AAAAAA

   
Results: 1-18 |
Results: 18
Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres
Authors: Iannone, MA Consler, TG Pearce, KH Stimmel, JB Parks, DJ Gray, JG
Citation: Ma. Iannone et al., Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres, CYTOMETRY, 44(4), 2001, pp. 326-337
Pharmacophore analysis of the nuclear oxysterol receptor LXR alpha
Authors: Spencer, TA Li, DS Russel, JS Collins, JL Bledsoe, RK Consler, TG Moore, LB Galardi, CM McKee, DD Moore, JT Watson, MA Parks, DJ Lambert, MH Willson, TM
Citation: Ta. Spencer et al., Pharmacophore analysis of the nuclear oxysterol receptor LXR alpha, J MED CHEM, 44(6), 2001, pp. 886-897
The synthesis of ethanolamine libraries from olefin scaffolds
Authors: Organ, MG Kaldor, SW Dixon, CE Parks, DJ Singh, U Lavorato, DJ Isbester, PK Siegel, MG
Citation: Mg. Organ et al., The synthesis of ethanolamine libraries from olefin scaffolds, TETRAHEDR L, 41(44), 2000, pp. 8407-8411
Studies on the mechanism of B(C6F5)(3)-catalyzed hydrosilation of carbonylfunctions
Authors: Parks, DJ Blackwell, JM Piers, WE
Citation: Dj. Parks et al., Studies on the mechanism of B(C6F5)(3)-catalyzed hydrosilation of carbonylfunctions, J ORG CHEM, 65(10), 2000, pp. 3090-3098
Identification of a chemical tool for the orphan nuclear receptor FXR
Authors: Maloney, PR Parks, DJ Haffner, CD Fivush, AM Chandra, G Plunket, KD Creech, KL Moore, LB Wilson, JG Lewis, MC Jones, SA Willson, TM
Citation: Pr. Maloney et al., Identification of a chemical tool for the orphan nuclear receptor FXR, J MED CHEM, 43(16), 2000, pp. 2971-2974
Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska, 1991-1998
Authors: Rudolph, KM Parkinson, AJ Reasonover, AL Bulkow, LR Parks, DJ Butler, JC
Citation: Km. Rudolph et al., Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska, 1991-1998, J INFEC DIS, 182(2), 2000, pp. 490-496
Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands
Authors: Moore, LB Parks, DJ Jones, SA Bledsoe, RK Consler, TG Stimmel, JB Goodwin, B Liddle, C Blanchard, SG Willson, TM Collins, JL Kliewer, SA
Citation: Lb. Moore et al., Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands, J BIOL CHEM, 275(20), 2000, pp. 15122-15127
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
Authors: Xu, HE Lambert, MH Montana, VG Parks, DJ Blanchard, SG Brown, PJ Sternbach, DD Lehmann, JM Wisely, GB Willson, TM Kliewer, SA Milburn, MV
Citation: He. Xu et al., Molecular recognition of fatty acids by peroxisome proliferator-activated receptors, MOL CELL, 3(3), 1999, pp. 397-403
Cat scratch disease - Posterior segment manifestations
Authors: Solley, WA Martin, DF Newman, NJ King, R Callanan, DG Zacchei, T Wallace, RT Parks, DJ Bridges, W Sternberg, P
Citation: Wa. Solley et al., Cat scratch disease - Posterior segment manifestations, OPHTHALMOL, 106(8), 1999, pp. 1546-1553
Bile acids: Natural ligands for an orphan nuclear receptor
Authors: Parks, DJ Blanchard, SG Bledsoe, RK Chandra, G Consler, TG Kliewer, SA Stimmel, JB Willson, TM Zavacki, AM Moore, DD Lehmann, JM
Citation: Dj. Parks et al., Bile acids: Natural ligands for an orphan nuclear receptor, SCIENCE, 284(5418), 1999, pp. 1365-1368
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation
Authors: Oberfield, JL Collins, JL Holmes, CP Goreham, DM Cooper, JP Cobb, JE Lenhard, JM Hull-Ryde, EA Mohr, CP Blanchard, SG Parks, DJ Moore, LB Lehmann, JM Plunket, K Miller, AB Milburn, MV Kliewer, SA Willson, TM
Citation: Jl. Oberfield et al., A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation, P NAS US, 96(11), 1999, pp. 6102-6106
A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat
Authors: Brown, KK Henke, BR Blanchard, SG Cobb, JE Mook, R Kaldor, I Kliewer, SA Lehmann, JM Lenhard, JM Harrington, WW Novak, PJ Faison, W Binz, JG Hashim, MA Oliver, WO Brown, HR Parks, DJ Plunket, KD Tong, WQ Menius, JA Adkison, K Noble, SA Willson, TM
Citation: Kk. Brown et al., A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat, DIABETES, 48(7), 1999, pp. 1415-1424
Differential activity of rosiglitazone enantiomers at PPAR gamma
Authors: Parks, DJ Tomkinson, NCO Villeneuve, MS Blanchard, SG Willson, TM
Citation: Dj. Parks et al., Differential activity of rosiglitazone enantiomers at PPAR gamma, BIOORG MED, 8(24), 1998, pp. 3657-3658
Synthesis, properties, and hydroboration activity of the highly electrophilic borane bis(pentafluorophenyl)borane, HB(C6F5)(2)
Authors: Parks, DJ Piers, WE Yap, GPA
Citation: Dj. Parks et al., Synthesis, properties, and hydroboration activity of the highly electrophilic borane bis(pentafluorophenyl)borane, HB(C6F5)(2), ORGANOMETAL, 17(25), 1998, pp. 5492-5503
Hydroboration of vinyl silanes with bis-(pentafluorophenyl)borane: ground state beta-silicon effects.
Authors: Parks, DJ Piers, WE
Citation: Dj. Parks et We. Piers, Hydroboration of vinyl silanes with bis-(pentafluorophenyl)borane: ground state beta-silicon effects., TETRAHEDRON, 54(51), 1998, pp. 15469-15488
N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents
Authors: Henke, BR Blanchard, SG Brackeen, MF Brown, KK Cobb, JE Collins, JL Harrington, WW Hashim, MA Hull-Ryde, EA Kaldor, I Kliewer, SA Lake, DH Leesnitzer, LM Lehmann, JM Lenhard, JM Orband-Miller, LA Miller, JF Mook, RA Noble, SA Oliver, W Parks, DJ Plunket, KD Szewczyk, JR Willson, TM
Citation: Br. Henke et al., N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents, J MED CHEM, 41(25), 1998, pp. 5020-5036
N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety
Authors: Collins, JL Blanchard, SG Boswell, GE Charifson, PS Cobb, JE Henke, BR Hull-Ryde, EA Kazmierski, WM Lake, DH Leesnitzer, LM Lehmann, J Lenhard, JM Orband-Miller, LA Gray-Nunez, Y Parks, DJ Plunkett, KD Tong, WQ
Citation: Jl. Collins et al., N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety, J MED CHEM, 41(25), 1998, pp. 5037-5054
N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent
Authors: Cobb, JE Blanchard, SG Boswell, EG Brown, KK Charifson, PS Cooper, JP Collins, JL Dezube, M Henke, BR Hull-Ryde, EA Lake, DH Lenhard, JM Oliver, W Oplinger, J Pentti, M Parks, DJ Plunket, KD Tong, WQ
Citation: Je. Cobb et al., N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent, J MED CHEM, 41(25), 1998, pp. 5055-5069
Risultati: 1-18 |